Who holds the cetuximab (Erbitux) patent(s), and what companies are involved?
Cetuximab is the active ingredient in Erbitux. The original patents and related exclusivities for cetuximab are tied to the drug’s developer and subsequent rights holders across different jurisdictions, but the specific “company” depends on which patent family you mean (early molecule patents vs. later formulations, manufacturing process, or country-specific extensions).
If you tell me the country (US, EU, UK, etc.) or the patent number you’re looking at, I can pinpoint the assignee/owner for that exact patent family.
What patent are people usually referring to for cetuximab?
When people search “cetuximab patent company,” they often mean one of these:
- Original composition-of-matter or key molecule patents (the main barrier to biosimilar entry).
- Extensions (example: method-of-use claims, combination/label expansions, or formulation/manufacturing improvements).
- Exclusivity protections (regulatory exclusivity can affect market entry even when some patents expire).
Different patents can list different assignees, so the “company” can change by patent type and by jurisdiction.
When do cetuximab patents/exclusivities expire (and which company controls the remaining protection)?
Patent expiry dates vary by country and by which specific patent family is still in force. Exclusivity can also delay entry even after some patents lapse. To answer this precisely, you need either:
- your jurisdiction, or
- the patent numbers / publication numbers you’ve found, or
- the biosimilar product name you’re comparing against (because timelines are tied to that product’s approval and reliance pathway).
Are biosimilars of cetuximab challenging the original patent(s)?
Biosimilar development commonly relies on showing the product can be approved without infringement of the still-in-force claims, and disputes can happen around claim scope and validity. The specific defendant/plaintiff companies depend on the lawsuit or patent challenge filings in a given country.
Quick way to get the exact “patent company” you need
Send any one of the following, and I’ll identify the assignee/company for the relevant cetuximab patent(s):
- Country (US/EU/UK/etc.)
- Patent number or publication number (e.g., WO, EP, US publication)
- Link to the patent page you found
- The product/biosimilar name you’re researching
Sources
No sources were provided in your prompt, so I can’t cite patent assignee details without you supplying a jurisdiction/patent number or providing source links.